(firstQuint)Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis.

 Acute invasive fungal infections caused by aspergillus, zygomycetes and other filamentous fungi remain life threatening diseases.

 Early treatment with highly effective anti-fungals reduces mortality.

 This study investigates the efficacy and safety of isavuconazole in the treatment of invasive fungal diseases, caused by Aspergillus or other filamentous fungi.

.

 Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis@highlight

The purpose of this study is to compare the efficacy and safety of isavuconazole versus voriconazole in the treatment of patients with invasive aspergillosis.

